Magnesium Acetate

Summary

Magnesium Acetate (CHEMBL1200691) is an approved small molecule.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Chemistry: 142.39 Da · C4H6MgO4

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL1200691
Name	Magnesium Acetate
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	8896
ChEBI	CHEBI:62964
Molecular formula	C4H6MgO4
Molecular weight	142.39
InChIKey	UEGPKNKPLBYCNK-UHFFFAOYSA-L

SMILES: CC(=O)[O-].CC(=O)[O-].[Mg+2]

IUPAC name: magnesium diacetate

ChEBI definition: The magnesium salt of acetic acid.

Also known as: Acetic acid, magnesium salt, Magnesium acetate, Magnesium acetate anhydrous, Magnesium acetate, mg(oac)2, NSC-75798, MAGNESIUM ACETATE, SID144209755

Parent form; salt/anhydrous children: CHEMBL3989858

Patent coverage: 25,130 distinct patent families (68,137 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).